Michael T Redman aka the "saint" has dedicated his life to making shareholders money and helping those in need. Oncolix is being set up to be his 3rd success and a likely buyout target for a larger pharmaceutical.
Redman and Payne have an incredible track record of taking companies from nothing to greatness. Oncolix won't be the first company Redman has sold after taking it all the way to Nasdaq. Shareholders in his previous deals have become overnight millionaires.
This guy really knows the ins and outs of building a successful pharmaceutical company. As soon as he saw Prolanta and it's potential, he immediately locked it down and formed Oncolix. Prolanta is setting up to be the greatest success of Redman's already amazing career. This has been 10 years in the making with incredible trial results so far. Prolanta is going to bring billions in revenue each year and big time millionaire investors have taken notice. Over $15 million of venture capital has already poured into Oncolix as the hype and excitement surrounding Prolanta couldn't be anymore real.
A little background on Prolanta. It was invented by the same scientist who created Somavert an extremely successful drug for Pfizer. This scientist is an absolute genius and has an unprecedented 100% success rate in developing FDA approved drugs. In order to protect Prolanta, Oncolix obtained 34 patents and market exclusivity as part of FDA orphan drug status.
Oncolix saving lives and making people wealthy!!!
Don't get left behind!!! A team full of the most successful management, doctors, and scientists about to make it rain for AEPP investors.
LETS GOOOO!!!!!
Market Data 
Markets 
AI
